The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse

  title={The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse},
  author={Andrew C. Kruegel and Oliver Grundmann},

Figures and Tables from this paper

The Potential for Kratom as an Antidepressant and Antipsychotic
The dire need for further research to be conducted on kratom, its mechanism of action and the constituents that elicit these antidepressant, anxiolytic, and antipsychotic properties is highlighted.
The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
The present data have shown that mitragynine is able to bind to opioid receptors, particularly MOR, to exhibit the analgesic effect and the updated pharmacological and toxicological properties of mitragyna speciosa and its diastereomers are discussed to render a comprehensive understanding of the pharmacological properties.
Oxidative Metabolism as a Modulator of Kratom's Biological Actions.
It is reported that metabolism of kratom's major alkaloid, mitragynine, in mice leads to formation of a potent mu opioid receptor agonist antinociceptive agent and the oxidative metabolism of the mitragysine template beyond 7-hydroxymitragynines may have implications in its overall pharmacology in vivo.
Identification and characterization of plant-derived alkaloids, corydine and corydaline, as novel mu opioid receptor agonists
Corydine and corydaline were identified as G protein-biased agonists to the MOR without inducing β-arrestin2 recruitment upon receptor activation, and represent valuable starting points for future chemical optimization towards the development of novel opioid analgesics, which may exhibit improved therapeutic profiles.
Evaluating kratom alkaloids using PHASE
The Public Health Assessment via Structural Evaluation (PHASE) protocol is applied to generate in silico binding profiles for 25 kratom alkaloids to facilitate the risk evaluation of kratom and demonstrates the ability of PHASE to identify potential safety signals and provide a tool for prioritizing experimental evaluation of high-risk compounds.
DARK Classics in Chemical Neuroscience: Kratom.
The traditional and medicinal uses of kratom are reviewed along with the synthesis of its bioactive ingredients, their pharmacology, metabolism, and structure-activity relationships, and the importance in society of this currently controversial substance are discussed.
7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects
It is found that mitragynine is converted in vitro in both mouse and human liver preparations to the much more potent mu-opioid receptor agonist 7-hydroxymitagynine and that this conversion is mediated by cytochrome P450 3A isoforms.
Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa)
Until studies are conducted that define kratom's role in treating opioid withdrawal and/or other central nervous system conditions, kratom will likely remain available as a dietary supplement for the foreseeable future.


Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa.
  • H. Takayama
  • Chemistry, Biology
    Chemical & pharmaceutical bulletin
  • 2004
The potent opioid agonistic activities of mitragynine, the major constituent of this plant, and its analogues were found in in vitro and in vivo experiments and the mechanisms underlying the analgesic activity were clarified, and 7-hydroxymitragynines, a minor constituent of M. speciosa, was found to exhibit potent antinociceptive activity in mice.
The pharmacology and toxicology of kratom: from traditional herb to drug of abuse
There are currently no standard analytical screening techniques for mitragynine and its metabolites following ingestion limiting its detection to more sophisticated techniques like liquid chromatography-mass spectrometry to determine kratom use.
Pharmacology of Kratom: An Emerging Botanical Agent With Stimulant, Analgesic and Opioid-Like Effects
Analyses of the medical literature and select Internet sites indicate that individuals in the United States are increasingly using kratom for the self-management of pain and opioid withdrawal.
Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands.
The oxidative derivatives of mitragynine were found as opioid agonists with higher potency than morphine in the experiment with guinea pig ileum, and 2 induced an analgesic activity in the tail flick test in mice.
Neurobiology of Kratom and its main alkaloid mitragynine
Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.
The Mitragyna alkaloid scaffold represents a novel framework for the development of functionally biased opioid modulators, which may exhibit improved therapeutic profiles and elucidation of previously unexplored structure-activity relationships within the Mitragynine scaffold.
Abuse potential and adverse cognitive effects of mitragynine (kratom)
Findings provide evidence for an addiction potential with cognitive impairments for mitragynine, which suggest its classification as a harmful drug.
From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction
Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.
3 developed analgesic tolerance more slowly than morphine, showed limited physical dependence, respiratory depression, constipation, and displayed no reward or aversion in CPP/CPA assays, suggesting that analogs might represent a promising new generation of novel pain relievers.